Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study

28 August 2017 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Lipid metabolism Lipids ESC Premium Access ESC Congress 2017

ESC 365 is supported by

ESC 365 is supported by